Amedisys Inc (AMED) Growth Rates Comparisons to Healthcare Facilities Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Amedisys Inc  (NASDAQ: AMED)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Amedisys Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMED Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 5.19 % 5.86 % 7.79 % 4.66 %
Q / Q Revenue Growth (Q2 MRQ) 4.55 % 2.49 % 6.43 % 4.04 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 4.92 % 3.81 % 6.19 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 1.29 % 1.44 % 1.72 % 1.17 %
Revenue 5 Year Average Growth 3.73 % 7.1 % 10.99 % 7.73 %


AMED's Growth Comparisons in II. Quarter 2025




Comparing 5.19% year on year top-line growth in the second quarter 2025, Amedisys Inc grew on the lower pace than the 5.86% growth in the Healthcare Facilities industry and 7.79% Revenue growth in the Healthcare sector. Above average sales gains in the Healthcare, as well as in the Healthcare Facilities industry, helped to elevate overall market growth to 4.66%.

Comparing the company's Revenue to the first quarter results, sales were higher by 4.55% . On the yearly basis, average annual sales growth for Amedisys Inc is 3.73%, while S & P 500's including only Businesses with the second quarter 2025 earnings, average annual sales growth is 7.73% over the past five years.

AMED Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Home Health Medicare
-2.78 %
-2.78 %
Home Health Non-Medicare - Episodic Based
12.5 %
12.5 %
Home Health Non-Medicare - Non-Episodic Based
5.26 %
0 %
Hospice Medicare
0 %
0 %
Hospice Non-Medicare
-50 %
-50 %
High Acuity Care
9.18 %
13.83 %
Home Health
4.98 %
4.48 %
Hospice
5.39 %
4.27 %
Total
5.19 %
4.55 %


Growth Rates of AMED's Income in the second quarter 2025


AMED Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) -12.71 % 13.68 % 56.6 % 10.34 %
Sequential Operating Income Change (Q2 MRQ) 5.12 % -0.16 % 17.79 % 4.86 %
Y / Y Operating Income Growth (Q2 TTM) -37.74 % 7.91 % 52.44 % 3.63 %
Sequential Operating Income Growth (Q2 TTM) -6.24 % 0.18 % 10.24 % 1.1 %
Operating Income 5 Year Avg. Change -11.84 % 9.92 % -0.96 % 9 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) -10.81 % 64.96 % 135.64 % 7.75 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -53.01 % 10.81 % 2.36 % 7.23 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -10.82 % 564.77 % 45.95 % 10.69 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -4.12 % 2.09 % 27.98 % 2.43 %
Income from Cont. Ops. 5 Year Avg. Change -21.49 % 16.69 % -17.93 % 8.34 %

AMED Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -10.81 % 61.35 % 132.89 % 9.34 %
Q / Q Net Income Growth (Q2 MRQ) -53.01 % 12.57 % 4.09 % 7.52 %
Y / Y Net Income Change (Q2 TTM) -10.82 % 17.95 % 58.51 % 10.17 %
Sequential Net Income Change (Q2 TTM) -4.12 % 13.05 % 20.63 % 2.82 %
Net Income 5 Year Avg. Growth -21.49 % 17.64 % 6.2 % 9.47 %

AMED's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) -14.14 % 10.46 % 135.64 % 7.75 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -54.3 % 12.9 % 2.36 % 7.23 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -7.6 % 1461.53 % - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -5.1 % 1.27 % - -37.11 %
EPS from Cont. Ops. 5 Year Avg. Growth -19.69 % -10.93 % -17.93 % 8.34 %



AMED EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) -14.29 % 8.04 % 132.89 % 8.34 %
Q / Q EPS Net Growth (Q2 MRQ) -54.35 % 14.7 % 4.09 % 7.52 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - 1856.83 % - -40.33 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -5.17 % 1.22 % - -37.11 %
EPS Net 5 Year Avg. Change -19.35 % 17.64 % 6.2 % 9.47 %



Amedisys Inc reported sharp income per share fall by -14.29% from the same quarter a year ago, in the second quarter, despite the rising EPS in Healthcare Facilities industry by 8.04%, and underperformed the 132.89% EPS surge in the Healthcare sector. Healthcare sector grew above market average, while Healthcare Facilities industry and Amedisys Inc results underperformed, in the second quarter.

Bottom-line fell by -54.35% from the first quarter results. Comparing the annual growth, income per share of -19.35% on average in last five years, to the S & P 500's, including only Businesses with the second quarter 2025 earnings, average yearly income per share growth is 9.47%. Amedisys Inc grew less than the market.

AMED Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 30.65 % 47.28 % 34.39 % -9.17 %
Sequential Free Cash Flow Change (Q2 MRQ) - 324.56 % 68.58 % 1036.6 %
Y / Y Free Cash Flow Change (Q2 TTM) 164.71 % 35.03 % 28.97 % -5.43 %
Sequential Free Cash Flow Change (Q2 TTM) 7.11 % 13.47 % 5.36 % -0.54 %
Free Cash Flow 5 Year Avg. Change 1.98 % 14.09 % 6.34 % 10.76 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) 43.02 % 186.21 % - -
Sequential Net Cash Flow Change (Q2 MRQ) - - - -
Y / Y Net Cash Flow Change (Q2 TTM) 289.52 % -19.85 % - -
Sequential Net Cash Flow Change (Q2 TTM) - 55.61 % - -
Net Cash Flow 5 Year Avg. Change 16.6 % 7.52 % -1.7 % -32.35 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -41.12 % -0.46 % 3.63 % 17.17 %
Sequential Capital Expenditures Change (Q2 MRQ) -34.68 % -0.16 % 4.53 % 11.05 %
Y / Y Capital Expenditures Change (Q2 TTM) -32.4 % 9.04 % 4.32 % 17.14 %
Sequential Capital Expenditures Change (Q2 TTM) -10.96 % 0.05 % 0.86 % 4.27 %
Capital Expenditures 5 Year Avg. Change -1.34 % 6.49 % 9.02 % 10.76 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.